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Bartonella species, transmitted by arthropods or animal 
bites and scratches, are emerging pathogens in human and 
veterinary medicine. PCR and DNA sequencing were used 
to test oral swabs collected from dogs. Results indicated the 
presence of 4 Bartonella species: B. bovis, B. henselae, B. 
quintana, and B. vinsonii subspecies berkhofﬁ  i.
B
artonella species are being recognized as increasingly 
important bacterial pathogens in veterinary and human 
medicine. These organisms can be transmitted by an arthro-
pod vector or alternatively by animal scratches or bites (1). 
Among the 11 species or subspecies known or suspected to 
be pathogenic in humans, 8 have been detected in or isolat-
ed from pet dogs or cats, thereby highlighting the zoonotic 
potential of these bacteria (2). In general, cats are impli-
cated in the transmission of Bartonella henselae, typically 
resulting in cat-scratch disease; however, there have also 
been sporadic reports of Bartonella transmission by dogs 
(3–5). When B. henselae prevalence was evaluated in a 
population of 52 dogs, 4 dogs were seroreactive at recipro-
cal titers of 64 or 128, and Bartonella-positive PCR results 
were found in 3 of 52 blood samples, 5 of 9 oral swabs, 
and 5 of 9 nail clippings (5). Based on these reports and the 
recent recognition of B. henselae and B. vinsonii subspe-
cies berkhofﬁ  i bacteremia in veterinarians and veterinary 
technicians who experience frequent cat and dog scratches 
and bites (6), we speculated that Bartonella species may be 
present in the saliva of dogs. The purpose of this study was 
to determine whether Bartonella DNA could be detected in 
oral swabs collected from dogs.
The Study
As part of an ongoing study from November 2004 
to December 2006 to investigate the prevalence of Ana-
plasma, Bartonella, and Ehrlichia infections in healthy 
golden retrievers and golden retrievers with lymphoma, a 
buccal swab was collected using a sterile cotton applica-
tor. The swab was placed against the inside surface of the 
dog’s cheek. Saliva and tissue were collected by rolling the 
swab ﬁ  rmly against the cheek. Subsequently, the swab was 
placed into a sterile, no additive, Vacutainer (Becton Dick-
inson, Franklin Lakes, NJ, USA) serum tube and allowed 
to air dry for 10 to 15 minutes at room temperature before 
the tube was recapped.
Cells on the air-dried swab were resuspended in 500 
μL of QuickExtract DNA Extraction Solution (EPICEN-
TRE Biotechnologies, Madison, WI, USA), according to 
the manufacturer’s instructions. Total DNA was isolated 
using 200 μL of the QuickExtract resuspension, which was 
extracted through a QIAamp DNA Blood Mini-Kit (QIA-
GEN, Inc., Valencia, CA, USA) according to the manu-
facturer’s instructions. Similarly, total DNA was extracted 
from 200 μL of EDTA-anticoagulated whole blood using 
the QIAamp DNA Blood Mini-Kit.
Oral swabs and blood samples (n = 44 each) were 
screened for the presence of Bartonella by 2 previously 
described PCR methods (7). The ﬁ  rst PCR targeted a frag-
ment of the 16S-23S intergenic transcribed spacer (ITS) re-
gion; samples that were PCR positive for Bartonella DNA 
by the ITS primers were subsequently analyzed by a second 
PCR targeting the heme-binding protein gene, Pap31. Posi-
tive and negative controls were used in all processing steps, 
including DNA extraction. PCR amplicons were sequenced 
to identify species (Davis Sequencing, Davis, CA, USA). 
Sequence analysis and alignment with GenBank sequences 
were performed (AlignX, Vector NTI Suite 6.0, InforMax, 
Inc., Frederick, MD, USA). Additionally, serum samples 
were analyzed for IgG antibodies to B. henselae and B. 
vinsonii (berkhofﬁ  i) using an indirect immunoﬂ  uorescence 
assay (IFA), as described previously (8). Reciprocal titers 
>64 were considered seroreactive.
Of the 44 dogs surveyed, oral swabs collected from 
5 (11.4%) dogs were PCR-positive for Bartonella DNA. 
Sequencing indicated that 5 different Bartonella species or 
subtypes were present: B. bovis, B. henselae, B. quintana, 
and B. vinsonii subsp. berkhofﬁ  i types I and II (Table). PCR 
ampliﬁ  cation and sequencing of blood samples from these 
5 dogs showed B. henselae and B. vinsonii ( berkhofﬁ  i) 
DNA in 2 dogs (Table). None of these 5 dogs was sero-
reactive to B. henselae or B. vinsonii (berkhofﬁ  i) antigens. 
Contamination was not detected in any of the negative con-
trol samples at any stage of processing or at any time dur-
ing the study. As this work was part of an ongoing study 
of golden retrievers with and without lymphoma, dogs 1 
and 2 had lymphoma; the remaining 3 dogs were clinically 
healthy (Table).
Conclusions
These results demonstrate the presence of Bartonella 
DNA in oral swabs obtained from dogs. Notably, 3 Bar-
tonella species and 2 B. vinsonii (berkhofﬁ  i) types were 
found in dog saliva. B. bovis, formerly referred to as B. 
weissii, was initially isolated from the blood of cats (9). 
Subsequently, this organism was isolated from the blood of 
cows in the United States, Europe, and Africa (10–12). To 
our knowledge, this is only the second known report of the 
detection of B. bovis DNA in a sample obtained from a dog 
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(13). All 5 dogs in this study lacked serologic evidence of 
Bartonella infection, a ﬁ  nding which has been previously 
reported in bacteremic dogs and humans (6,13,14).
Previous studies have shown that targeting multiple 
Bartonella genes provides molecular evidence of coin-
fection with more than 1 Bartonella species or strain type 
(6,7,13). In the current work, the inability to conﬁ  rm the ITS 
PCR results with a second PCR target has been previously 
reported by our laboratory (6,13,14) and likely reﬂ  ects dif-
ferences in PCR sensitivity, interference or inhibition of the 
PCR reaction by oral bacteria that are present in greater 
numbers than the Bartonella, or the lack of a known heme-
binding protein gene in various Bartonella species, such as 
B. bovis. The limit of detection (LOD) of Bartonella ITS 
PCR is 2 copies/reaction, while the LOD of Pap31 assay 
is 10 copies/reaction. Further, although B. henselae has a 
detectable Pap31 protein (Table), several researchers in our 
laboratory have successfully isolated B. henselae strains 
that lack a PCR-detectable heme-binding protein (unpub. 
data). Upon recognition of the discordance between ITS 
and Pap31, additional genes such as 16S, gltA, and rpoB 
were targeted; however, these analyses were negative for 
Bartonella and resulted in nonspeciﬁ  c bacterial ampliﬁ  ca-
tion. Because inhibition of ITS PCR was suspected due the 
presence of other oral bacteria, Bartonella-negative DNA 
extracts from oral swabs were spiked with B. henselae 
DNA at 1.5, 2.5, 5, and 10 (0.002 pg/μL) copies/reaction. 
Inhibition was detected at up to 5 copies/reaction, while 
the 10 copies/reaction sample was consistently ampliﬁ  ed 
by the ITS primers.
These data, in conjunction with previous case reports 
(3–5), suggest that potentially viable Bartonella organ-
isms may be transmitted to humans after a dog bite. The 
detection of DNA by PCR does not necessarily indicate 
the viability of Bartonella organisms. However, due to the 
extremely slow growth characteristics of Bartonella spp., 
isolation from the oral cavity does not seem feasible, be-
cause of competition with numerous other rapidly growing 
oral bacterial species. Recently, Bartonella DNA has been 
ampliﬁ  ed from peripheral lymph nodes of healthy dogs 
(14). B. henselae was also ampliﬁ  ed from salivary gland 
tissues from a dog with saladenitis (15). There are several 
plausible routes by which a Bartonella sp. could gain entry 
to the oral cavity. Future studies should determine if the 
tonsilar lymphoid tissues, salivary glands, or periodontal, 
gingival, or other oral tissues can serve as sources of Bar-
tonella spp. contamination of canine saliva. As Bartonella 
infection may represent an occupational risk for veterinary 
professionals and others with extensive animal contact (6), 
additional studies should address the risk of transmission 
from dogs to humans following bite wounds.
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